Profile data is unavailable for this security.
About the company
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is focused on enhanced personalized cancer care through remote patient monitoring using implantable vascular access port with wireless communication combined with an oncologist-designed remote digital healthcare platform.
- Revenue in USD (TTM)3.83m
- Net income in USD-67.35m
- Incorporated2014
- Employees107.00
- LocationPAVmed Inc360 Madison Avenue, 25Th FloorNEW YORK 10017United StatesUSA
- Phone+1 (212) 949-4319
- Fax+1 (302) 655-5049
- Websitehttps://pavmed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Precipio Inc | 16.72m | -3.83m | 9.10m | 51.00 | -- | 0.7448 | -- | 0.5444 | -2.68 | -2.68 | 11.73 | 8.24 | 0.9089 | 17.12 | 16.80 | 327,843.10 | -20.82 | -44.98 | -27.94 | -58.68 | 39.08 | 28.80 | -22.90 | -118.07 | 0.590 | -192.59 | 0.0517 | -- | 61.46 | 39.62 | 52.04 | -- | 5.37 | -- |
| Sigyn Therapeutics Inc | 0.00 | -3.70m | 9.15m | 5.00 | -- | -- | -- | -- | -3.08 | -3.08 | 0.00 | -2.91 | 0.00 | -- | -- | 0.00 | -1,085.72 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0247 | -2.09 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| T2 Biosystems Inc | 7.16m | -48.26m | 9.16m | 113.00 | -- | -- | -- | 1.28 | -10.70 | -10.70 | 1.09 | -0.3391 | 0.2435 | 2.82 | 5.41 | 63,398.23 | -164.01 | -106.01 | -- | -253.03 | -86.96 | -12.60 | -673.67 | -317.93 | 0.359 | -12.44 | 2.00 | -- | -67.75 | -7.29 | 19.66 | -- | -20.19 | -- |
| Applied DNA Sciences Inc | 3.40m | -7.52m | 9.44m | 53.00 | -- | 0.1554 | -- | 2.78 | -11.86 | -11.86 | 2.18 | 1.20 | 0.2092 | 6.83 | 5.68 | 64,114.15 | -45.51 | -88.57 | -55.20 | -121.91 | 25.04 | 44.35 | -217.48 | -113.26 | 3.76 | -- | 0.00 | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
| PetVivo Holdings Inc | 975.28k | -10.11m | 9.80m | 20.00 | -- | 11.76 | -- | 10.05 | -0.6705 | -0.6705 | 0.062 | 0.0417 | 0.3257 | 0.405 | 16.37 | 48,764.00 | -337.63 | -230.77 | -589.09 | -467.99 | 83.60 | 66.21 | -1,036.50 | -1,501.44 | 0.455 | -1,075.05 | 0.0221 | -- | 5.62 | -- | -25.67 | -- | 23.91 | -- |
| QT Imaging Holdings Inc | 0.00 | -4.02m | 10.24m | -- | -- | 0.471 | -- | -- | -0.3999 | -0.3999 | 0.00 | 1.01 | 0.00 | -- | -- | -- | -12.32 | -- | -16.60 | -- | -- | -- | -- | -- | -- | -- | 0.3042 | -- | -- | -- | -45.07 | -- | -- | -- |
| REMSleep Holdings Inc | 144.88k | -1.81m | 10.26m | 6.00 | -- | 17.84 | -- | 70.82 | -0.0012 | -0.0012 | 0.0001 | 0.0004 | 0.08 | 1.69 | 4.75 | -- | -99.82 | -152.40 | -122.32 | -317.98 | -491.08 | -- | -1,246.94 | -2,317.52 | 1.47 | -43.58 | 0.1207 | -- | -36.48 | -- | 12.13 | -- | 28.26 | -- |
| Guided Therapeutics Inc | 38.00k | -2.39m | 10.78m | 4.00 | -- | -- | -- | 283.66 | -0.0444 | -0.0444 | 0.0007 | -0.0829 | 0.0211 | 0.0365 | 8.44 | 9,500.00 | -120.81 | -136.13 | -- | -- | 42.11 | 29.39 | -5,721.05 | -3,666.67 | 0.0679 | -7.58 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Innovative Eyewear Inc | 1.53m | -7.86m | 10.90m | 11.00 | -- | 1.44 | -- | 7.13 | -11.01 | -11.01 | 2.05 | 4.81 | 0.1779 | 1.97 | 15.91 | 139,070.90 | -91.45 | -- | -96.06 | -- | -2.46 | -- | -514.10 | -- | 12.85 | -- | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| Golden Valley Development Inc | 0.00 | -92.53k | 11.63m | 0.00 | -- | -- | -- | -- | -11.17 | -11.17 | 0.00 | -0.0211 | 0.00 | -- | -- | -- | -7,710.83 | -- | -- | -- | -- | -- | -- | -3,073.27 | -- | -3.96 | -- | -- | -- | -- | 45.48 | -- | -- | -- |
| SeaStar Medical Holding Corp | 0.00 | -33.23m | 11.65m | 12.00 | -- | -- | -- | -- | -21.41 | -21.41 | 0.00 | -2.14 | 0.00 | -- | -- | 0.00 | -1,145.80 | -- | -- | -- | -- | -- | -- | -- | -- | -9.51 | -- | -- | -- | -- | -115.19 | -- | -- | -- |
| PAVmed Inc | 3.83m | -67.35m | 11.66m | 107.00 | -- | -- | -- | 3.04 | -8.17 | -8.17 | 0.4595 | -7.74 | 0.0823 | -- | 29.45 | 35,785.05 | -155.93 | -154.56 | -- | -1,152.82 | -77.59 | -- | -1,895.64 | -8,764.89 | 0.5529 | -8.16 | 1.74 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
| Autonomix Medical Inc | -100.00bn | -100.00bn | 12.21m | 5.00 | -- | 1.93 | -- | -- | -- | -- | -- | 5.50 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.1647 | -- | -- | -- | -674.99 | -- | -- | -- |
| STRATA Skin Sciences Inc | 32.73m | -8.31m | 12.81m | 99.00 | -- | 1.13 | -- | 0.3913 | -2.37 | -2.37 | 9.35 | 2.71 | 0.6906 | 3.47 | 7.81 | 330,606.10 | -17.54 | -11.48 | -24.26 | -16.55 | 54.30 | 61.28 | -25.40 | -17.70 | 0.9176 | -2.69 | 0.6141 | -- | -7.75 | 2.24 | -95.17 | -- | 23.29 | -- |
| BioRegenx Inc | 1.29m | -4.28m | 12.96m | 10.00 | -- | 0.9114 | -- | 10.03 | -0.0053 | -0.0053 | 0.0023 | 0.0149 | 0.1438 | -- | -- | 129,234.00 | -47.59 | -- | -58.94 | -- | 66.76 | -- | -331.00 | -- | 0.0533 | -28.81 | 0.1284 | -- | -47.25 | -- | -629.37 | -- | -- | -- |
| Meihua International Medical Tech Co Ltd | 94.25m | 9.28m | 14.10m | 617.00 | 1.45 | 0.0872 | 1.45 | 0.1496 | 0.3442 | 0.3442 | 3.45 | 5.73 | 0.5516 | 46.02 | 1.16 | 152,759.40 | 5.42 | 12.26 | 6.43 | 15.05 | 33.12 | 38.14 | 9.84 | 15.47 | 4.74 | -- | 0.0729 | 0.00 | -6.05 | 5.10 | 86.22 | -5.56 | -9.16 | -- |
Data as of Nov 13 2024. Currency figures normalised to PAVmed Inc's reporting currency: US Dollar USD
13.64%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| First Manhattan Co LLCas of 30 Jun 2024 | 500.00k | 4.81% |
| Ayrton Capital LLCas of 31 Dec 2023 | 382.98k | 3.68% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 293.59k | 2.82% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 74.91k | 0.72% |
| Geode Capital Management LLCas of 30 Jun 2024 | 73.63k | 0.71% |
| Two Sigma Securities LLCas of 30 Jun 2024 | 25.23k | 0.24% |
| Obermeyer Wood Investment Counsel LLLPas of 30 Sep 2024 | 21.50k | 0.21% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 20.85k | 0.20% |
| Virtu Americas LLCas of 30 Jun 2024 | 15.10k | 0.15% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 2024 | 11.71k | 0.11% |
More ▼
Data from 30 Jun 2024 - 14 Oct 2024Source: FactSet Research Systems Inc.
